For the first time, a drug from a new class of potent cholesterol-lowering therapies has been shown to cut the risk of death, heart attack and stroke. Here’s guidance on whether it’s right for you.
Newer cholesterol-lowering drugs combined with more conventional medicine reduces bad cholesterol to incredibly low levels, a new study shows. Perhaps even more important, the combination also reduces the heart-attack-inducing plaque that forms inside the arteries.
Could PCSK9 inhibitors, a new class of cholesterol-busting drugs, be right for you? Here are 4 things you need to know about these powerful drugs, which can help lower your bad (LDL) cholesterol by up to 50 to 70 percent.
Two new drugs to help physicians better manage “bad” cholesterol (LDL cholesterol) have received approval this week from an FDA advisory panel. The FDA typically accepts those recommendations, so the drugs may soon be available for patient use. The new drugs – both injectables – are called alirocumab (brand name, Praluent), which received the panel’s … Read More
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Two new medications for cardiovascular disease may be life-changing. These “spectacular therapeutic breakthroughs both have enormous potential,” wrote Steven Nissen, MD, Chair of Cardiovascular Medicine at Cleveland Clinic, in a post on MedPage Today. There have not been changes this big in heart therapeutics in more than a decade, he says. Ask your doctor if either of … Read More
Every year, Cleveland Clinic presents the top 10 medical innovations — the most influential and potentially beneficial breakthroughs in medicine for the year.
The 63rd annual meeting of the American College of Cardiology brought together leading experts in cardiovascular medicine. The result was a heady mix of promising new medications, old medications revisited, and links found between dietary conditions, unusual lifestyle factors and heart disease. 1. New generation cholesterol lowering drug PCSK9 inhibitors are the new potential game … Read More
Updates showing positive results in ongoing trials of a new type of cholesterol-lowering drug generated a lot of interest at the American College of Cardiology’s (ACC) recent annual meeting in Washington, D.C. Still in their trial phase, the PCSK9 inhibitor-type drugs show encouraging promise as a new treatment option for statin-intolerant patients. Answer to statin … Read More
Cholesterol-lowering statins are highly effective in reducing heart attacks and stroke. But they don’t work for everyone, and sometimes, they can cause intolerable side effects. For these patients in particular, PCSK9 inhibitors bring new hope. A new class of drugs, PCSK9 inhibitors lower levels of “bad” LDL cholesterol in a different way than statins. They … Read More